Fifty years of experience with loxapine for the rapid non-coercive tranquilization of acute behavioral disturbances in schizophrenia patients, and beyond-Reference-Cited by-同舟云学术

Fifty years of experience with loxapine for the rapid non-coercive tranquilization of acute behavioral disturbances in schizophrenia patients, and beyond

Published:2022-08-03 Issue:8 Volume:22 Page:639-653
ISSN:1473-7175
Container-title:Expert Review of Neurotherapeutics
language:en
Short-container-title:Expert Review of Neurotherapeutics

Author:

Nuss Philippe¹^ORCID,Corruble Emmanuelle²,Baloche Emmanuelle³,P. Garay Ricardo⁴^ORCID,Llorca Pierre-Michel⁵^ORCID

Affiliation:

1. Department of Adult Psychiatry and Medical Psychology, Sorbonne University, Saint-Antoine Hospital, Paris, France & Inserm UMR-S938, Saint-Antoine Research Centre, Sorbonne University, Paris, France

2. INSERM CESP-Team ‘Moods,’ Paris-Saclay University & Department of Psychiatry, Bicetre Hospital & School of Medicine Paris-Saclay, Le Kremlin Bicetre, France

3. Medical Advisor Neurosciences, Eisai SAS, La Défense, France

4. Department of Pharmacology and Therapeutics, Craven, Villemoisson-sur-Orge & CNRS, National Centre of Scientific Research, Paris, France

5. Department of Psychiatry, University Hospital, Clermont Ferrand, France

Funder

Eisai SAS

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Neurology (clinical),General Neuroscience

Link

https://www.tandfonline.com/doi/pdf/10.1080/14737175.2022.2108706

Reference124 articles.

1. The Psychopharmacology of Agitation: Consensus Statement of the American Association for Emergency Psychiatry Project BETA Psychopharmacology Workgroup

2. Assessment and management of agitation in psychiatry: Expert consensus

3. Joint BAP NAPICU evidence-based consensus guidelines for the clinical management of acute disturbance: De-escalation and rapid tranquillisation

4. Managing Agitation Associated with Schizophrenia and Bipolar Disorder in the Emergency Setting

5. Characterizing the experience of agitation in patients with bipolar disorder and schizophrenia